X-Linked Agammaglobulinemia (XLA) — Preventing Infections Before They Start
Note: Real cases, names and ages have been changed for privacy.
The Family
Sarah and Daniel were first-time parents to baby Ava. She seemed healthy at birth, but by four months old, she had already had two serious infections requiring hospitalization. They asked their pediatrician about genetic screening through Fore Genomics and the pediatrician agreed it was a good idea.
The Genetic Finding
Ava’s screening identified a mutation in the BTK gene, associated with X-linked agammaglobulinemia (XLA)—a rare immune disorder where the body can’t produce antibodies. Children with XLA are highly vulnerable to infections, especially in their early years.
The Impact
- Ava was referred to a pediatric immunologist right away.
- She began monthly immunoglobulin infusions to boost her immune system.
- Her family was educated on how to minimize exposure to infections.
- Her care team delayed and modified her vaccine schedule, particularly the MMR vaccine, which contains live virus components and is typically given at 12 months. This vaccine can pose serious risks for children with XLA. Because her condition was known, she was protected from this potential risk.
- For the first time since Ava’s birth, Sarah and Daniel felt like they were finally one step ahead of her health challenges.
Today, Ava is a thriving 4-year-old with far fewer infections, living a full life thanks to proactive care from a timely genetic diagnosis.
Why It Matters
Without screening, Ava might have faced years of unexplained infections and even severe complications from routine childhood vaccinations. With Fore Genomics’ test, her parents were empowered to act early and safely.
Final Takeaway
Genetic screening is not about fear — it’s about preparation. These case studies show how insights from DNA can:
- Prevent emergencies
- Enable early treatment
- Guide lifelong health decisions
- For children like Ava, early answers can be the difference between recurring hospital stays and a healthy childhood
At Fore Genomics, we help parents unlock the hidden health information in their child’s DNA — because knowledge today can change tomorrow.
FAQs
What is X-linked agammaglobulinemia (XLA)?
XLA is a rare inherited immune disorder in which the body can’t produce antibodies, leaving children highly vulnerable to infections, especially in their early years.
How can genetic screening help with a condition like XLA?
Identifying it early lets a care team begin preventive treatment, such as immunoglobulin infusions, and safely adjust the vaccine schedule before serious infections occur.